Moreover, in the patients with MTC, CD8+ TIL levels were significantly lower in the high-HHLA2 expression group compared with the low expression group, suggesting the immunosuppressive function of HHLA2. The gene discussed is HHLA2; the disease is medullary thyroid gland carcinoma.